We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Fisher & Paykel Healthcare Corporation Limited is a medical instruments & supplies business based in Australia. Fisher-and-Paykel Healthcare Corporation shares (FPH) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Fisher-and-Paykel Healthcare Corporation has a trailing 12-month revenue of around $2 billion. If you're looking to buy shares, check out the steps below.
How to buy shares in Fisher-and-Paykel Healthcare Corporation
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Fisher-and-Paykel Healthcare Corporation. Find the share by name or ticker symbol: FPH. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Fisher-and-Paykel Healthcare Corporation reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Fisher-and-Paykel Healthcare Corporation. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Fisher-and-Paykel Healthcare Corporation key stats
- Compare share trading platforms
- Is Fisher-and-Paykel Healthcare Corporation stock a buy or sell?
- Fisher-and-Paykel Healthcare Corporation performance over time
- Are Fisher-and-Paykel Healthcare Corporation shares over-valued?
- Fisher-and-Paykel Healthcare Corporation's financials
- How volatile are Fisher-and-Paykel Healthcare Corporation shares?
- Does Fisher-and-Paykel Healthcare Corporation pay a dividend?
- Have Fisher-and-Paykel Healthcare Corporation shares ever split?
- Other common questions
Fisher-and-Paykel Healthcare Corporation share priceUse our graph to track the performance of FPH stocks over time.
Fisher-and-Paykel Healthcare Corporation shares at a glance
|52-week range||$25.25 - $34.7585|
|50-day moving average||$29.8536|
|200-day moving average||$30.0708|
|Dividend yield||$0.38 (1.32%)|
|Earnings per share (TTM)||$0.838|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Fisher-and-Paykel Healthcare Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Fisher-and-Paykel Healthcare Corporation price performance over time
|1 week (2021-06-11)||-0.61%|
|1 month (2021-05-21)||-11.60%|
|3 months (2021-03-19)||-2.78%|
|6 months (2020-12-21)||-10.62%|
|1 year (2020-06-19)||2.68%|
|2 years (2019-06-21)||91.80%|
|3 years (2018-06-21)||95.19%|
|5 years (2016-06-21)||179.35%|
Is Fisher-and-Paykel Healthcare Corporation under- or over-valued?
Valuing Fisher-and-Paykel Healthcare Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fisher-and-Paykel Healthcare Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fisher-and-Paykel Healthcare Corporation's P/E ratio
Fisher-and-Paykel Healthcare Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Fisher-and-Paykel Healthcare Corporation shares trade at around 34x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Fisher-and-Paykel Healthcare Corporation's PEG ratio
Fisher-and-Paykel Healthcare Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.4677. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fisher-and-Paykel Healthcare Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Fisher-and-Paykel Healthcare Corporation's EBITDA
Fisher-and-Paykel Healthcare Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $781.3 million.
The EBITDA is a measure of a Fisher-and-Paykel Healthcare Corporation's overall financial performance and is widely used to measure a its profitability.
Fisher-and-Paykel Healthcare Corporation financials
|Revenue TTM||$2 billion|
|Operating margin TTM||36.13%|
|Gross profit TTM||$1.2 billion|
|Return on assets TTM||25.37%|
|Return on equity TTM||42.03%|
|Market capitalisation||$16.5 billion|
TTM: trailing 12 months
Fisher-and-Paykel Healthcare Corporation share dividends
Dividend payout ratio: 34.87% of net profits
Recently Fisher-and-Paykel Healthcare Corporation has paid out, on average, around 34.87% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.26% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Fisher-and-Paykel Healthcare Corporation shareholders could enjoy a 1.26% return on their shares, in the form of dividend payments. In Fisher-and-Paykel Healthcare Corporation's case, that would currently equate to about A$0.38 per share.
While Fisher-and-Paykel Healthcare Corporation's payout ratio might seem fairly standard, it's worth remembering that Fisher-and-Paykel Healthcare Corporation may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 23 June 2021 (the "ex-dividend date").
Have Fisher-and-Paykel Healthcare Corporation's shares ever split?
Fisher-and-Paykel Healthcare Corporation's shares were split on a 5:1 basis on 26 September 2004. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Fisher-and-Paykel Healthcare Corporation shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Fisher-and-Paykel Healthcare Corporation shares which in turn could have impacted Fisher-and-Paykel Healthcare Corporation's share price.
Fisher-and-Paykel Healthcare Corporation share price volatility
Over the last 12 months, Fisher-and-Paykel Healthcare Corporation's shares have ranged in value from as little as $25.25 up to $34.7585. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Fisher-and-Paykel Healthcare Corporation's is -0.157. This would suggest that Fisher-and-Paykel Healthcare Corporation's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Fisher-and-Paykel Healthcare Corporation has bucked the trend.
Fisher-and-Paykel Healthcare Corporation overview
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. It also provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
Frequently asked questions
More guides on Finder
Bitcoin’s better half: Growing number of Australian women investing in crypto
Despite Bitcoin’s volatile value changes this year, Australians are still flocking to cryptocurrency in droves, with 17% of the population now owning a form of cryptocurrency.
Amazon Prime Day best Australian alcohol deals: Up to 38% off
Stock up on the good stuff this Prime Day, with these big booze offers.
How to buy iShares Global 100 AUD Hedged ETF units
Steps to owning and managing iShares Global 100 AUD Hedged ETF units.
Amazon Prime Day best book deals for all ages: Up to 55% off
Snap up best-selling reads for the whole family with these great Australian Prime Day offers.
Best Prime Day deals 2021: Highlights from day one [updated]
The wait is finally over. Here are the best Amazon Prime Day deals you can get in Australia right now.
Toyota LandCruiser 300 series: Release date, specs, price, models and more
Toyota popped the bonnet on its highly anticipated 2022 Toyota Landcruiser 300 series 4WD in June 2021. Here's everything you need to know.
Ethereum price continues to slide, correcting by 9% overnight
Crypto experts believe that ETH may still be able to go on a bull run later on this year after the ongoing bearish pressure subsides.
Amazon Prime Day 2021: Best Xbox and PC game deals
Whether you're a shiny Xbox owner or a proud member of the PC master race, Amazon Prime Day has what you're looking for.
Prime Day Coke deal: Get 57% off select multi-packs
Amazon's bonkers Coca-Cola deal is back for Prime Day - and this time it's brought Fanta and Sprite along to the party. Save up to 57%!
Amazon Prime Day best deals from local Aussie brands: Up to 45% off
Here are the Prime Day deals you can feel especially good about shopping.
Ask an Expert